News Update: Johnson & Johnson Recalled Two Hip Replacement Products, 11th Recall Since September

http://bit.do/dLv27 Secret sale page FxMath.
Johnson & Johnson's (NYSE:JNJ) artificial joint business is recalling two hip replacement products, which is the company's 11th recall since September. DePuy Orthopaedics Inc. said it is recalling two hip replacement products because new data shows higher-than-expected rates of patients needing a second hip replacement procedure. One in eight patients needed a revision surgery within five years, which is required when an artificial joint doesn't fit perfectly, causing pain and difficulty walking. David Floyd, president of DePuy Orthopaedics said, ""We are committed to assisting patients and healthcare providers by providing information through multiple channels and paying for the cost of doctor visits, tests and procedures associated with the recall."" SmarTrend alerted subscribers to take profits in Johnson & Johnson on May 06, 2010 at $62.56, since then the stock fell 7.5%. We are now watching for any positive developments that could result in a new uptrend signal.